PI3Kα-IN-6
PI3Kα-IN-6 (Compound 5b) is a PI3Kα inhibitor. PI3Kα-IN-6 exhibits anticancer potential and no toxicity in normal cells. PI3Kα-IN-6 increases generation of ROS, reduces mitochondrial membrane potential (MMP) and induces apoptosis[1].
Product Specifications
CAS Number
2272894-14-9
UNSPSC
12352005
Target
Apoptosis; PI3K; Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pi3kα-in-6.html
Solubility
10 mM in DMSO
Smiles
COC1=CC=C(C=C1)SCC2=C(N=C3C=CC(C)=CN32)I
Molecular Formula
C16H15IN2OS
Molecular Weight
410.27
References & Citations
[1]Singh D, et al. Synthesis of 3-N-/O-/S-methyl-imidazo[1,2-a] pyridine derivatives for caspase-3 mediated apoptosis induced anticancer activity.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PI3Kα
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD8A (Cytotoxic- & Suppressor T-Cell Marker) (UCHT4), CF594 conjugate, 0.1mg/mL
CD79a (B-Cell Marker) (rIGA/764), CF647 conjugate, 0.1mg/mL
